This Activity Plan outlines key activities to be undertaken in 2017–18 through the Strengthening the capacity, efficiency and effectiveness of Clinical Trials Networks through the Australian Clinical Trials Alliance program (the Program). The Activity Plan has been developed in consultation with the Australian Clinical Trials Alliance (ACTA) Advisory Council, ACTA Board and the Department of Health.
The activities described represent the first priorities required to develop, implement and support a national framework to expand the capacity, capability, efficiency and effectiveness of Clinical Trials Networks (CTNs) in Australia. By supporting and coordinating this strategic program of work, ACTA will facilitate the development of a dynamic and responsive roadmap for the future, that builds on the sector’s significant strengths and expertise.
The programs of work will be led by and informed by the sector. ACTA will provide the central coordination and program support required to progress key priorities, and will maintain an active program of engagement with the sector to ensure that the work program informs and is informed by member priorities, expertise and needs. This will include the provision of direct one-to-one support and mentoring to support the development of new CTNs and accelerate the dissemination and adoption of guidance and best practices among existing CTNs.
The scale of ambition described in this Activity Plan reflects the size and potential impact of the opportunity ahead. ACTA is committed to working closely with Government, our members and the broader health and research sector in Australia to achieve the aims of the Program. The Activity Plan defines key milestones and proposed approaches to collaboration, engagement and dissemination. Our approach will be revised and refined over time, building on and learning from early sector consultation and mapping activity, and ensuring that our strategic work programs lead to practical outputs that can be implemented across the sector.